<DOC>
	<DOCNO>NCT01375881</DOCNO>
	<brief_summary>The purpose non-interventional study description use darunavir daily practice , retrospective perspective manner . Darunavir prescribe usual manner accordance term market authorization . The assignment patient particular therapeutic strategy decide advance study protocol instead , part current clinical practice . The prescription medicinal product clearly separated decision include patient study . No additional diagnostic monitoring procedure apply patient , epidemiological method use analysis collect data . After agree patient start treatment darunavir , provide inclusion exclusion criterion apply , physician document patient 's data . Patients observe least 48 week baseline visit except withdraw study earlier . Patients data collect approximately 0 , 1 , 3 6 month start treatment subsequently every 3 month accordance routine practice . The expected number patient enroll 900 . The patient treat darunavir accord Italian label . The patient must withdraw study treatment darunavir stop . A last evaluation must document possible , resistance test collect available patient discontinue virologic failure . At end study visit , information therapy give darunavir discontinuation collect . For patient discontinue virologic failure , data collect end present study , least two consecutive measurement viral load start new antiretroviral therapy collect , available . All data collect must result normal medical care patient . The patient 's baseline data collect within first week darunavir administration ( Visit 1 ) . For patient already treatment darunavir , baseline follow data collect retrospectively prospectively . Further data collection occur approximately 1 , 3 , 6 month subsequently every 3 month accord routine practice , initiate darunavir treatment .</brief_summary>
	<brief_title>Non-interventional Study Use Darunavir With Ritonavir Clinical Practice</brief_title>
	<detailed_description>The patient 's baseline data collect within first week darunavir administration , Visit 1 . For patient already treatment darunavir , outside Early Access Program , baseline follow-up data collect retrospectively prospectively . For patient switched commercial darunavir Early Access Program already treatment darunavir , Baseline Visit data collect Early Access Program Baseline Visit . For patient already treatment darunavir outside Early Access Program , baseline data collect retrospectively start first darunavir intake . For patient , laboratory examination result collect within 6 month darunavir treatment start consider baseline data . For patient switched commercial darunavir Early Access Program already treatment darunavir , Visit 2 wo n't perform . For patient start commercial darunavir already treatment commercial darunavir outside Early Access Program , laboratory exam relate follow-up visit , Visit 2 onward , perform within time window one month correspond visit date . Further data collection occur approximately 1 , 3 , 6 month subsequently every 3 month accord routine practice , initiate darunavir treatment . If patient stop treatment darunavir time , end study visit perform soon possible . Darunavir film-coated tablet , orally administer . Orange , oval-shaped tablet , debossed 400MG 600MG 300MG one side TMC side . Duration observation minimum 48 week .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Darunavir</mesh_term>
	<criteria>Eligible inclusion noninterventional study adult patient need treatment darunavir accord Italian label already treatment Having provide sign date Informed Consent Form A known hypersensitivity darunavir excipients Severe hepatic impairment describe ChildPugh class C Pregnancy lactation Patient previously treat darunavir discontinue reason</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>HIV</keyword>
	<keyword>darunavir</keyword>
	<keyword>ritonavir</keyword>
	<keyword>Prezista</keyword>
	<keyword>naive</keyword>
	<keyword>experienced</keyword>
</DOC>